FDA pilot aims to boost transparency for oncology tests

Regulatory NewsRegulatory NewsBiologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsCombination products/companion diagnosticsComplianceDiagnostics/IVDsEthicsNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyResearch, Design and Development